ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome

AgelessRx · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
covid19, long covid-19, post-covid-19 syndrome, covid-19, naltrexone, nad, nicotinamide adenine dinucleotide, low dose naltrexone, ldn, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 901345
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.